We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
-12.55%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$4.23B
AUM Growth
-$736M
Cap. Flow
-$44.3M
Cap. Flow %
-1.05%
Top 10 Hldgs %
39.91%
Holding
175
New
7
Increased
67
Reduced
32
Closed
14

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$52.1M
2
CTVA icon
Corteva
CTVA
+$14.2M
3
UPS icon
United Parcel Service
UPS
+$5.57M
4
JCI icon
Johnson Controls International
JCI
+$4.53M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.02M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$31.4M
2
ABBV icon
AbbVie
ABBV
+$26M
3
QCOM icon
Qualcomm
QCOM
+$14M
4
NKE icon
Nike
NKE
+$13.6M
5
SAP icon
SAP
SAP
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 39.88%
2 Healthcare 24.89%
3 Industrials 13.56%
4 Consumer Staples 9.34%
5 Consumer Discretionary 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
26
Illinois Tool Works
ITW
$81.4B
$57.8M 1.37%
317,061
+30
+0% +$6K
ORCL icon
27
Oracle
ORCL
$331B
$54.8M 1.3%
783,968
+300
+0% +$22K
BMY icon
28
Bristol-Myers Squibb
BMY
$127B
$52.7M 1.25%
684,207
+530
+0.1% +$40.4K
GPC icon
29
Genuine Parts
GPC
$17.1B
$52.6M 1.24%
395,285
+240
+0.1% +$31.9K
AZN icon
30
AstraZeneca
AZN
$263B
$52.4M 1.24%
+396,837
New +$52.1M
AMD icon
31
Advanced Micro Devices
AMD
$851B
$51.1M 1.21%
668,035
-6,159
-0.9% -$577K
MKC icon
32
McCormick & Company Non-Voting
MKC
$13.4B
$47.7M 1.13%
573,460
+790
+0.1% +$74.8K
ABT icon
33
Abbott
ABT
$180B
$47.6M 1.13%
438,470
-711
-0.2% -$80.7K
NEM icon
34
Newmont
NEM
$98.2B
$47.5M 1.12%
796,050
+2,150
+0.3% +$152K
CNI icon
35
Canadian National Railway
CNI
$78.3B
$45.9M 1.09%
408,000
– –
HON icon
36
Honeywell
HON
$77.1B
$45.6M 1.08%
278,175
– –
PPG icon
37
PPG Industries
PPG
$25.9B
$44.2M 1.05%
386,500
+2,500
+0.7% +$312K
IT icon
38
Gartner
IT
$9.41B
$43.7M 1.03%
180,641
– –
QCOM icon
39
Qualcomm
QCOM
$176B
$42.7M 1.01%
334,195
-103,060
-24% -$14M
TXN icon
40
Texas Instruments
TXN
$255B
$41.1M 0.97%
267,187
+580
+0.2% +$97.6K
LIN icon
41
Linde
LIN
$237B
$39.3M 0.93%
136,528
– –
LECO icon
42
Lincoln Electric
LECO
$13.8B
$38.3M 0.91%
310,700
– –
GWW icon
43
W.W. Grainger
GWW
$65.3B
$37.2M 0.88%
81,851
+130
+0.2% +$63.2K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$3.91T
$35.3M 0.84%
324,380
+800
+0.2% +$94.2K
INTC icon
45
Intel
INTC
$466B
$34.8M 0.82%
930,512
+1,381
+0.1% +$59.7K
CL icon
46
Colgate-Palmolive
CL
$72.6B
$34.8M 0.82%
433,966
– –
FAST icon
47
Fastenal
FAST
$54B
$32.1M 0.76%
1,284,600
– –
KMB icon
48
Kimberly-Clark
KMB
$36.4B
$31.8M 0.75%
234,950
– –
ABBV icon
49
AbbVie
ABBV
$458B
$30M 0.71%
195,971
-169,930
-46% -$26M
HD icon
50
Home Depot
HD
$332B
$30M 0.71%
109,287
-475
-0.4% -$140K
1
2
3 4 5

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return

Saturna Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Saturna Capital held 175 positions worth $4.23B, down 15% from $4.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Saturna Capital's Q2 2022 filing shows 7 new, 67 increased, 32 reduced and 14 closed positions. Its largest new stake was AstraZeneca: 396,837 shares worth $52.4M. The largest sale was Eli Lilly, an estimated $31.4M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 44% a quarter earlier, followed by Healthcare and Industrials.

  • Saturna Capital's largest Q2 2022 buy was AstraZeneca: 396,837 shares worth $52.4M.
  • Saturna Capital added most to Corteva in Q2 2022, an estimated $14.2M increase.
  • Saturna Capital's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $31.4M.
  • Saturna Capital fully exited SAP in Q2 2022, selling an estimated $13.6M.
  • Saturna Capital's ten largest holdings make up 40% of its $4.23B portfolio in Q2 2022.
  • Saturna Capital opened 7 new positions and closed 14 in Q2 2022.
  • Saturna Capital's portfolio value fell 15% quarter-over-quarter to $4.23B.

Based on Saturna Capital's 13F filing for Q2 2022, filed 12 Aug 2022.